Martine Boyer | Director Protein Science
IQVIA Inc.

With over 25 years of experience in the biopharmaceutical industry, Martine brings deep expertise in protein sciences, including molecular biology, recombinant protein expression, purification, and biophysical characterization. Her work has contributed to the development of robust immunological tools and assay platforms that support a wide range of research, including advancements in vaccine development. Martine began her career at Biochem Pharma and Shire, followed by a key role at ID Biomedical focused on immunological assays. She later joined GlaxoSmithKline, contributing to the Recombinant Antigen Vaccines Design team and leading R&D projects in protein science. Her responsibilities expanded to managing a team of scientists and establishing best practices in protein characterization. Her leadership continued at Neomed-Labs and Nexelis, and now at IQVIA Laboratories in the Discovery Unit, where she supports innovation in specialty laboratory services. Martine is known for her strategic mindset, organizational strength, and commitment to delivering scientifically rigorous, client-focused solutions.